Bronchitis - Pipeline Review, H2 2018

Publisher Name :
Date: 11-Sep-2018
No. of pages: 76
Inquire Before Buying

Bronchitis - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchitis - Pipeline Review, H2 2018, provides an overview of the Bronchitis (Respiratory) pipeline landscape.

Bronchitis is an inflammation of the lining of bronchial tubes, which carry air to and from lungs. Symptoms include cough that produces mucus (sputum), which may be blood streaked, shortness of breath aggravated by exertion or mild activity, frequent respiratory infections that worsen symptom, wheezing, fatigue, ankle that affects both sides and headaches. Risk factors include smoking, low resistance and gastric reflux.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Bronchitis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Bronchitis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 3, 3, 3, 4 and 1 respectively.

Bronchitis (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Bronchitis (Respiratory).

- The pipeline guide reviews pipeline therapeutics for Bronchitis (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Bronchitis (Respiratory) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Bronchitis (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Bronchitis (Respiratory)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Bronchitis (Respiratory).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Bronchitis (Respiratory) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Bronchitis - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bronchitis - Overview
Bronchitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Bronchitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Bronchitis - Companies Involved in Therapeutics Development
Advanced Inhalation Therapies (AIT) Ltd
AstraZeneca Plc
Daewon Pharm Co Ltd
DBV Technologies SA
F. Hoffmann-La Roche Ltd
Han Wha Pharma Co Ltd
Icure Pharmaceutical Inc
Kyorin Pharmaceutical Co Ltd
Merck & Co Inc
Onspira Therapeutics Inc
Orbis Biosciences Inc
Therabron Therapeutics Inc
Bronchitis - Drug Profiles
alteplase - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
alvelestat - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CG-367 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cyclosporine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DW-1601 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
formoterol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HOB-051 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lascufloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nitric oxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pirfenidone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
prednisone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Protein to Antagonize IL1B for Bronchiolitis Obliterans - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SNSP-146 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
solithromycin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YJP-40 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bronchitis - Dormant Projects
Bronchitis - Discontinued Products
Bronchitis - Product Development Milestones
Featured News & Press Releases
Apr 26, 2018: AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
Dec 01, 2017: AIT Therapeutics Announces Publication of Its Phase 2 Trial in Bronchiolitis Patients in the Pediatric Pulmonology Journal
Nov 21, 2017: AIT Therapeutics to Hold Clinical Update Meeting on November 28, 2017
Jan 23, 2017: Therabron Therapeutics Receives Orphan Drug Designation in the European Union for CG367, Indicated for the Treatment of Bronchiolitis Obliterans Syndrome
Jun 23, 2015: Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets
Apr 21, 2015: Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings
Feb 03, 2014: AIT To Present Noxcurebr At The Annual Meeting Of The Israeli Association Of Clinical Pediatrics
Jan 19, 2014: AIT To Present Phase II Clinical Data for NOxCureBR, A Treatment for Acute Bronchiolitis and RSV in Infants
Jan 15, 2013: DBV Technologies And INRA Receive Funding To Develop Pediatric Bronchiolitis Vaccine
Feb 11, 2010: PARI Pharma Enrolls First Patient In Phase IIb Study Of L-CsA
Jun 02, 2009: PARI Pharma Reports Successful Phase Ib Clinical Results For Inhaled Liposomal Cyclosporine A And Gains FDA Orphan Drug Designation For The Prevention And Treatment Of Bronchiolitis Obliterans
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Bronchitis, H2 2018
Number of Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Bronchitis - Pipeline by Advanced Inhalation Therapies (AIT) Ltd, H2 2018
Bronchitis - Pipeline by AstraZeneca Plc, H2 2018
Bronchitis - Pipeline by Daewon Pharm Co Ltd, H2 2018
Bronchitis - Pipeline by DBV Technologies SA, H2 2018
Bronchitis - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018
Bronchitis - Pipeline by Han Wha Pharma Co Ltd, H2 2018
Bronchitis - Pipeline by Icure Pharmaceutical Inc, H2 2018
Bronchitis - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2018
Bronchitis - Pipeline by Merck & Co Inc, H2 2018
Bronchitis - Pipeline by Onspira Therapeutics Inc, H2 2018
Bronchitis - Pipeline by Orbis Biosciences Inc, H2 2018
Bronchitis - Pipeline by Therabron Therapeutics Inc, H2 2018
Bronchitis - Dormant Projects, H2 2018
Bronchitis - Dormant Projects, H2 2018 (Contd..1), H2 2018
Bronchitis - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Bronchitis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018
  • Allergic Rhinitis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 141
    Allergic Rhinitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H2 2018, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape. Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhi......
  • Global Positive Airway Pressure Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Sep-2018        Price: US 3480 Onwards        Pages: 117
    Non-invasive positive pressure ventilation refers to ventilation without artificial airway (endotracheal intubation or tracheotomy). It is an artificial ventilation method that connects the ventilator to the patient through a nasal mask and completes the ventilation assisted by the ventilator by providing positive pressure support. Scope of the Report: This report focuses on the Positive Airway Pressure Devices in global market, especially in North America, Europe and As......
  • Cystic Fibrosis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 435
    Cystic Fibrosis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H2 2018, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited disease that causes mucus to build up and clog some of the body's organs, particularly the lungs and pancreas. Cystic fibrosis affects the cells that produce mucus, sw......
  • Malignant Pleural Effusion - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 43
    Malignant Pleural Effusion - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Pleural Effusion - Pipeline Review, H2 2018, provides an overview of the Malignant Pleural Effusion (Respiratory) pipeline landscape. Malignant pleural effusion is a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue (pleura) lining the outside of th......
  • Global Mechanical Ventilators Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Mechanical ventilation is a lifesaving intervention for patients with respiratory disorders or even respiratory failure. It is a form of breathing assistance in which a patient is connected to a ventilator through an endotracheal tube directly applied to the airway. Scope of the Report: This report focuses on the Mechanical Ventilators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes th......
  • Global Pulmonary Function Testing Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Sep-2018        Price: US 3480 Onwards        Pages: 130
    Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function. The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease. Scope of th......
  • Global Medical Oxygen Machine Market Research Report 2018
    Published: 08-Sep-2018        Price: US 3500 Onwards        Pages: 127
    Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Portable medical oxygen concentrator Stationary medical oxygen concentrator Others By Application Home Hospital Traveling Others By Company Invacare Teijin Pharma Chart Industries Inogen......
  • Global Portable Oxygen Concentrators Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 07-Sep-2018        Price: US 3480 Onwards        Pages: 137
    An oxygen concentrator is a medical device which is designed to deliver a concentrated flow of oxygen to a patient. Portable oxygen concentrators are small, lightweight and more convenient for the patients. In fact, oxygen concentrators are rather simple devices. They operate on the principle of ‘rapid pressure swing adsorption' of atmospheric nitrogen onto specific minerals and then venting the nitrogen. The filtered gas mixture is mainly oxygen and little other gasses like argon and CO2......
  • Global Medical Hyperbaric Oxygen Chamber Equipment Market Research Report 2018
    Published: 07-Sep-2018        Price: US 3500 Onwards        Pages: 117
    Summary Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Monoplace Chambers Multiplace Chambers By Application Hospitals Clinics Others By Company Sechrist Industries ETC BIOMEDICAL SYSTEMS OxyHeal Health Group Gulf Coast Hyperbarics Fink Engineering......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs